CSLLY Projected Dividend Yield
ADR (Sponsored)/CSL Ltd ( OTCBB : CSLLY )CSL is engaged in the research, development, manufacture, marketing and distribution of biopharmaceutical products and vaccines. Co.'s operating segments are: CSL Behring and CSL Seqirus. Co.'s CSL Behring segment manufactures, markets, and distributes plasma therapies (plasma products and recombinants), conducts early-stage research on plasma and non-plasma therapies, excluding influenza, and focuses on the commercialization of intellectual property. Co.'s CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products and develops influenza related products. 20 YEAR PERFORMANCE RESULTS |
CSLLY Dividend History Detail CSLLY Dividend News CSLLY Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
2024 |
N/A |
Sep 10, 2024 |
Sep 10, 2024 |
Oct 09, 2024 |
0.6750 |
2024 |
N/A |
Mar 11, 2024 |
Mar 12, 2024 |
Apr 10, 2024 |
0.5450 |
2024 Total: |
1.2200 |
||||
2023 |
N/A |
Sep 08, 2023 |
Sep 11, 2023 |
Oct 10, 2023 |
0.5950 |
2023 |
N/A |
Mar 08, 2023 |
Mar 09, 2023 |
Apr 11, 2023 |
0.4850 |
2023 Total: |
1.0800 |
||||
2022 |
N/A |
Sep 02, 2022 |
Sep 06, 2022 |
Oct 11, 2022 |
0.5400 |
2022 |
N/A |
Mar 04, 2022 |
Mar 07, 2022 |
Apr 11, 2022 |
0.4700 |
2022 Total: |
1.0100 |
||||
2021 |
N/A |
Sep 01, 2021 |
Sep 02, 2021 |
Oct 05, 2021 |
0.5400 |
2021 |
N/A |
Mar 03, 2021 |
Mar 04, 2021 |
Apr 06, 2021 |
0.4700 |
2021 Total: |
1.0100 |
||||
2020 |
N/A |
Sep 09, 2020 |
Sep 10, 2020 |
Oct 19, 2020 |
0.4850 |
2020 |
N/A |
Mar 10, 2020 |
Mar 11, 2020 |
Apr 20, 2020 |
0.4119 |
2020 Total: |
0.8969 |
||||
2019 |
N/A |
Sep 09, 2019 |
Sep 10, 2019 |
Oct 21, 2019 |
0.4427 |
2019 |
N/A |
Mar 14, 2019 |
Mar 15, 2019 |
Apr 22, 2019 |
0.3804 |
2019 Total: |
0.8231 |